The 2022 JADPRO Live conference was held in person from October 20 to 23 in Aurora, Colorado. I was excited to finally see peers I had only met virtually throughout these past 2 years. Numerous advanced practitioner–designed sessions on solid tumors and hematologic malignancies were held. Notable presentations included the opening panel discussion on oncology pregnancy and fertility concerns, the keynote address titled “Letting” by BJ Miller, MD, and a biomarker session with an interactive format that I was fortunate to be a part of. There were opportunities to learn even more with non-certified satellite symposia and independent satellite symposia, along with networking events such as peer roundtables and Braindate.
JADPRO Live is also a time to come together and celebrate our colleagues and their tireless contributions to advanced practice and patient care. The recipient of the fifth annual Mary Pazdur Award for Excellence in Advanced Practice was Carrie Tompkins Stricker, PhD, RN, ANP-BC, CRNP, executive director of Canopy Cancer Collective and an associate professor at Thomas Jefferson University College of Nursing, who I have known for many years. The Outstanding Poster Award went to the team led by Kathryn E. Slane, MSN, AGPCNP-BC, AOCNP®, for JL1030C: The Development of a Biomarker Database: Creating a Clinical Decision Support Tool for Oncology Nurses and Advanced Practice Providers. See the next issue for complete clinical poster abstracts accepted this year. Don't forget to check out the JADPRO Article of the Year, “Management of hematologic adverse events associated with immune checkpoint inhibitors” by Barbara Barnes Rogers, CRNP, MN, AOCN®, ANP-BC, and colleagues in the May/June 2021 issue.
There was time to relax too with pre-conference tours and a welcome reception on Thursday night. The exhibit hall was a lively place, with industry representatives providing valuable resources and a booth offering complimentary professional headshots. The JADPRO Associate Editors and I also had our annual meeting to discuss future directions of the journal. We have many exciting things planned and can't wait to share these with you in the coming year.
I hope you enjoyed the sessions and format this year at JADPRO Live. Those unable to attend the in-person event were treated to a JADPRO Live Virtual Day held with brand-new presentations on November 5. Remember, on-demand access for all 26 CE presentations (both from the in-person event and Virtual Day) will remain available through December 31. Personally, I found the discussions during both the live and virtual sessions very interesting and look forward to returning to some that I missed.
A well-deserved recognition of efforts in coordinating this year's conference goes to the conference chair and an esteemed colleague, Jennifer Webster, MN, MPH, RN, AOCNS®. Jennifer and the organizing committee did an amazing job at creating a well-rounded agenda filled with content delivered by renowned faculty. Some interesting numbers from the conference are:
1,300 in-person attendees
26.5 CE credits/contact hours available
36 clinical posters, 41 industry encore posters, and 14 patient posters presented
If you were unable to attend this year, we hope to see you at next year's conference to be held November 9 through 12 in sunny Orlando, Florida!
IN THIS ISSUE
The last issue of this year is full of interesting articles to round out your year. Faith Mutale, DNP, CRNP, writes on a critical issue: the importance of diversity and inclusion in clinical trials and how far we still have to go to increase racial and ethnic minority patient enrollment in cancer clinical trials. Two quality improvement projects describe a model of AP-led shared survivorship visits and an intervention to improve adherence to prophylactic anticonvulsant guidelines for newly diagnosed brain tumor patients. The learnings from these projects have broad applicability across many different settings. In our Review column, read about considerations in using liquid biopsy in non–small cell lung cancer and a meta-analysis on same-day pegfilgrastim administration.
A case study details how to manage liver dysfunction in a patient on sotorasib, and the Practice Matters article provides insights into the unique experiences of AP fellows during the COVID-19 pandemic. Finally, test your knowledge on a patient with rare leukemia in Diagnostic Snapshot. We would like to thank all the peer reviewers who volunteer their time and expertise toward making this journal a reliable and current resource for all oncology advanced practitioners.
Finally, I want to thank each and every one of you for choosing to be a part of and engaging in this JADPRO community. Best wishes for health and happiness in the coming year!